Product Information
PROCHLORPERAZINE 5 MG TABLET is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.1155 per EA under NDC 68462088901. Its NADAC has been published 133 times since Dec 13, 2023.
Strength
5 mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462088901
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PROCHLORPERAZINE MALEATEApproval Type
Generic (ANDA)
FDA Application
ANDA216595On Market Since
3/17/2023
Pharmacological Classes
Price Statistics
The NADAC for PROCHLORPERAZINE 5 MG TABLET has been published 133 times since Dec 13, 2023, and over the history we have for it it has declined 58.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1155 per EA |
|---|---|
| All-time high | $0.2871 (Feb 14, 2024) |
| All-time low | $0.1153 (Apr 22, 2026) |
| 52-week high | $0.1662 |
| 52-week low | $0.1153 |
| Median price | $0.1531 |
| Average price | $0.1677 |
| Largest weekly change | +71.7% (Aug 21, 2024) |
| Weeks tracked | 133 |
| Tracking since | Dec 13, 2023 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PROCHLORPERAZINE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PROCHLORPERAZINE 5 MG TABLET, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.1155 per EA (NDC 68462088901), effective Jun 24, 2026.
How has the price of PROCHLORPERAZINE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for PROCHLORPERAZINE 5 MG TABLET has declined 58.0%. It has been tracked across 133 weekly CMS publications since Dec 13, 2023.
What are the highest and lowest recorded NADAC prices for PROCHLORPERAZINE 5 MG TABLET?
Since Dec 13, 2023, the NADAC for PROCHLORPERAZINE 5 MG TABLET has ranged from a low of $0.1153 (Apr 22, 2026) to a high of $0.2871 (Feb 14, 2024), with a median of $0.1531 per EA.
Are there cheaper alternatives to PROCHLORPERAZINE 5 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as PROCHLORPERAZINE 5 MG TABLET, but none are currently priced below it.
Who manufactures PROCHLORPERAZINE 5 MG TABLET?
PROCHLORPERAZINE 5 MG TABLET (NDC 68462088901) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.
Related Drugs
Same classification